These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8943258)

  • 1. Bax homodimerization is not required for Bax to accelerate chemotherapy-induced cell death.
    Simonian PL; Grillot DA; Andrews DW; Leber B; Nuñez G
    J Biol Chem; 1996 Dec; 271(50):32073-7. PubMed ID: 8943258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bax can antagonize Bcl-XL during etoposide and cisplatin-induced cell death independently of its heterodimerization with Bcl-XL.
    Simonian PL; Grillot DA; Merino R; Nuñez G
    J Biol Chem; 1996 Sep; 271(37):22764-72. PubMed ID: 8798452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proapoptotic protein Bax heterodimerizes with Bcl-2 and homodimerizes with Bax via a novel domain (BH3) distinct from BH1 and BH2.
    Zha H; Aimé-Sempé C; Sato T; Reed JC
    J Biol Chem; 1996 Mar; 271(13):7440-4. PubMed ID: 8631771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-function analysis of Bcl-2 family proteins. Regulators of programmed cell death.
    Reed JC; Zha H; Aime-Sempe C; Takayama S; Wang HG
    Adv Exp Med Biol; 1996; 406():99-112. PubMed ID: 8910675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax.
    Yin XM; Oltvai ZN; Korsmeyer SJ
    Nature; 1994 May; 369(6478):321-3. PubMed ID: 8183370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The BH3 domain of Bax is sufficient for interaction of Bax with itself and with other family members and it is required for induction of apoptosis.
    Simonen M; Keller H; Heim J
    Eur J Biochem; 1997 Oct; 249(1):85-91. PubMed ID: 9363757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BID: a novel BH3 domain-only death agonist.
    Wang K; Yin XM; Chao DT; Milliman CL; Korsmeyer SJ
    Genes Dev; 1996 Nov; 10(22):2859-69. PubMed ID: 8918887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the anti-apoptotic mechanism of Bcl-B.
    Zhai D; Ke N; Zhang H; Ladror U; Joseph M; Eichinger A; Godzik A; Ng SC; Reed JC
    Biochem J; 2003 Nov; 376(Pt 1):229-36. PubMed ID: 12921534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutagenesis of the BH3 domain of BAX identifies residues critical for dimerization and killing.
    Wang K; Gross A; Waksman G; Korsmeyer SJ
    Mol Cell Biol; 1998 Oct; 18(10):6083-9. PubMed ID: 9742125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MAP-1, a novel proapoptotic protein containing a BH3-like motif that associates with Bax through its Bcl-2 homology domains.
    Tan KO; Tan KM; Chan SL; Yee KS; Bevort M; Ang KC; Yu VC
    J Biol Chem; 2001 Jan; 276(4):2802-7. PubMed ID: 11060313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple Bcl-2 family members demonstrate selective dimerizations with Bax.
    Sedlak TW; Oltvai ZN; Yang E; Wang K; Boise LH; Thompson CB; Korsmeyer SJ
    Proc Natl Acad Sci U S A; 1995 Aug; 92(17):7834-8. PubMed ID: 7644501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. harakiri, a novel regulator of cell death, encodes a protein that activates apoptosis and interacts selectively with survival-promoting proteins Bcl-2 and Bcl-X(L).
    Inohara N; Ding L; Chen S; Núñez G
    EMBO J; 1997 Apr; 16(7):1686-94. PubMed ID: 9130713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regions outside of the Bcl-2 homology domains, BH1 and BH2 protect a dopaminergic neuronal cell line from staurosporine-induced cell death.
    Oh YJ; Uhland-Smith A; Kim JE; O'Malley KL
    Brain Res Mol Brain Res; 1997 Nov; 51(1-2):133-42. PubMed ID: 9427515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterodimerization-independent functions of cell death regulatory proteins Bax and Bcl-2 in yeast and mammalian cells.
    Zha H; Reed JC
    J Biol Chem; 1997 Dec; 272(50):31482-8. PubMed ID: 9395483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peptides derived from BH3 domains of Bcl-2 family members: a comparative analysis of inhibition of Bcl-2, Bcl-x(L) and Bax oligomerization, induction of cytochrome c release, and activation of cell death.
    Shangary S; Johnson DE
    Biochemistry; 2002 Jul; 41(30):9485-95. PubMed ID: 12135371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bcl-2 is a monomeric protein: prevention of homodimerization by structural constraints.
    Conus S; Kaufmann T; Fellay I; Otter I; Rossé T; Borner C
    EMBO J; 2000 Apr; 19(7):1534-44. PubMed ID: 10747022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural and functional complementation of an inactive Bcl-2 mutant by Bax truncation.
    Ottilie S; Diaz JL; Chang J; Wilson G; Tuffo KM; Weeks S; McConnell M; Wang Y; Oltersdorf T; Fritz LC
    J Biol Chem; 1997 Jul; 272(27):16955-61. PubMed ID: 9202007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A common binding site mediates heterodimerization and homodimerization of Bcl-2 family members.
    Diaz JL; Oltersdorf T; Horne W; McConnell M; Wilson G; Weeks S; Garcia T; Fritz LC
    J Biol Chem; 1997 Apr; 272(17):11350-5. PubMed ID: 9111042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-function analysis of Bcl-2 protein. Identification of conserved domains important for homodimerization with Bcl-2 and heterodimerization with Bax.
    Hanada M; Aimé-Sempé C; Sato T; Reed JC
    J Biol Chem; 1995 May; 270(20):11962-9. PubMed ID: 7744846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural basis of BFL-1 for its interaction with BAX and its anti-apoptotic action in mammalian and yeast cells.
    Zhang H; Cowan-Jacob SW; Simonen M; Greenhalf W; Heim J; Meyhack B
    J Biol Chem; 2000 Apr; 275(15):11092-9. PubMed ID: 10753914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.